progesterone

AssetAlso Progestrone vaginal insert

Activates progesterone receptors to support pregnancy and maintain uterine quiescence.

Stage: Approved
Modality: Small molecule
Target: PGR; 7
Indications: 159
Trials: 6
Developers

Indications

7

Amenorrhea
Approved, accessdata.fda.gov, 7 Oct 2026
Endometrial hyperplasia
Approved, accessdata.fda.gov, 7 Oct 2026
In vitro fertilization
Phase 3, Completed, NCT00696878, clinicaltrials.gov, 7 Oct 2026

4 more

In the full profile

Targets and what it contains1
Owner and partners6
Trials159
Evidence for its targets2
Competitors9
Signals2

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 10 Oct 2026, 24 sources